A study to evaluate the influence of Body Mass Index on kinetic of B-cell repopulation after treatment with Ocrelizumab in patients with multiple sclerosis
Latest Information Update: 04 Jul 2020
At a glance
- Drugs Ocrelizumab (Primary)
- Indications Multiple sclerosis
- Focus Pharmacodynamics
Most Recent Events
- 04 Jul 2020 New trial record
- 26 May 2020 Results presented at the 6th Congress of the European Academy of Neurology